WAVE Life Sciences Ltd
NASDAQ:WVE

Watchlist Manager
WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd
NASDAQ:WVE
Watchlist
Price: 6.9 USD 4.7% Market Closed
Market Cap: 1.1B USD

Wall Street
Price Targets

WVE Price Targets Summary
WAVE Life Sciences Ltd

Wall Street analysts forecast WVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WVE is 21.59 USD with a low forecast of 10.1 USD and a high forecast of 37.8 USD.

Lowest
Price Target
10.1 USD
46% Upside
Average
Price Target
21.59 USD
213% Upside
Highest
Price Target
37.8 USD
448% Upside
WAVE Life Sciences Ltd Competitors:
Price Targets
HITI
High Tide Inc
133% Upside
NEU
Neuren Pharmaceuticals Ltd
110% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
10% Upside
GUD
Knight Therapeutics Inc
30% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
20% Upside
300765
CSPC Innovation Pharmaceutical Co Ltd
12% Downside
SHILPAMED
Shilpa Medicare Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
WAVE Life Sciences Ltd

For the last 8 years the compound annual growth rate for WAVE Life Sciences Ltd's revenue is 78%. The projected CAGR for the next 3 years is 16%.

78%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
WAVE Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
WAVE Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WVE's stock price target?
Price Target
21.59 USD

According to Wall Street analysts, the average 1-year price target for WVE is 21.59 USD with a low forecast of 10.1 USD and a high forecast of 37.8 USD.

What is WAVE Life Sciences Ltd's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for WAVE Life Sciences Ltd's revenue is 78%. The projected CAGR for the next 3 years is 16%.

Back to Top